万维百科英文版

Coronavirus disease 2019

  (Redirected from COVID-19)
Coronavirus disease 2019
(COVID-19)
Other names
  • 2019-nCoV acute respiratory disease
  • Novel coronavirus pneumonia[1]
  • Wuhan pneumonia[2][3][4][5]
Symptoms of coronavirus disease 2019 (cropped).png
Symptoms
Pronunciation
  • /kə'ronavaırəs dızi:z/
SpecialtyAcute respiratory infection [6]
SymptomsFever, cough, shortness of breath[7]
ComplicationsPneumonia, ARDS, kidney failure
CausesSARS-CoV-2
Diagnostic methodPCR testing, medical imaging
TreatmentSymptomatic and supportive

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-CoV-2,[8] a virus closely related to the SARS virus.[9][10][11] The disease is the cause of the 2019–20 coronavirus outbreak.[12][13] It is primarily spread between people by small droplets from infected individuals when they breathe or cough.[14][15] Time from exposure to onset of symptoms is generally between 2 and 14 days.[16][17] Hand washing, maintaining distance from people who are coughing, and not touching one's face is recommended to prevent the disease.[18] It is recommended to cover one's nose and mouth with a bent elbow when coughing.[19]

People may have few symptoms or develop fever, cough, and shortness of breath.[20][21][7] Cases can progress to pneumonia and multi-organ failure.[12][13] There is no vaccine or specific antiviral treatment, with management involving treatment of symptoms, supportive care, and experimental measures.[22] The case fatality rate is estimated at between 1% and 3%.[23][24]

The World Health Organization (WHO) and U.S. Centers for Disease Control (CDC) recommend those who suspect that they are carrying the virus wear a surgical face mask and seek medical advice by calling a doctor rather than directly visiting a clinic in person. Masks are also recommended for those who are taking care of someone with a suspected infection. Masks are not recommended for the general public.[25][26] The WHO has declared the 2019–20 coronavirus outbreak to be a Public Health Emergency of International Concern (PHEIC).[27][28] While as of 19 February 2020, only Mainland China was listed as an area with known ongoing community spread of the disease, by 28 February 2020, other countries including Italy and Iran were included in the list.[29][30]

Signs and symptoms

Those infected may either be asymptomatic or develop symptoms including fever, cough or shortness of breath.[20][21][7] Diarrhea or upper respiratory symptoms (e.g. sneezing, runny nose, sore throat) are less frequent.[31] Cases can progress to pneumonia, multi-organ failure, and death.[12][13]

The incubation period ranges from 1 to 14 days with an estimated median incubation period of 5 to 6 days according to the World Health Organization.[32][33] A study found rare cases where the incubation period was as long as 27 days.[34][35]

Cause

Scanning electron microscope image of SARS-CoV-2 (centre, yellow)

The disease is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), previously referred to as the 2019 novel coronavirus (2019-nCoV).[10] It is primarily spread between people via respiratory droplets from coughs and sneezes.[36]

The virus is thought to have an animal origin.[37] An epidemiological study of the first 72,314 cases released by the Chinese government suggested that there may have been a "continuous common source" of the outbreak in December 2019, which would imply that several animal to human zoonotic events occurred at the Huanan Seafood Wholesale Market. According to this theory, the primary source of infection became human-to-human transmission in early January 2020.[38]

Diagnosis

CDC laboratory test kit for COVID-19[39]

The WHO has published several testing protocols for the disease.[40][41] Testing uses real time reverse transcription-polymerase chain reaction (rRT-PCR).[42] The test can be done on respiratory samples.[43] Results are generally available within a few hours to days.[44][45] Blood tests can be used, but these require two blood samples taken two weeks apart and the results have little immediate value.[46] Chinese scientists were able to isolate a strain of the coronavirus and publish the genetic sequence so that laboratories across the world could independently develop PCR tests to detect infection by the virus.[12][47][48][49] COVID 19 testing can also be done with nucleic acid-based tests and antibody test kits.[50]

Diagnostic guidelines released by Zhongnan Hospital of Wuhan University suggested methods for detecting infections based upon clinical features and epidemiological risk. These involved identifying patients who had at least two of the following symptoms in addition to a history of travel to Wuhan or contact with other infected patients: fever, imaging features of pneumonia, normal or reduced white blood cell count, or reduced lymphocyte count.[51]

Prevention

Global health organisations have published preventive measures to reduce the chances of infection. Recommendations are similar to those published for other coronaviruses: staying home, avoiding travel and public activities, frequent washing of hands with soap and water; not touching the eyes, nose, or mouth with unwashed hands; and practicing good respiratory hygiene.[52][53]

The use of masks by healthy members of the public is not recommended outside of China.[54][55][56]

To prevent transmission, the CDC recommends that infected individuals stay at home except to get medical care; call ahead before visiting a healthcare provider; wear a facemask (especially in public); cover coughs and sneezes with a tissue; regularly wash hands with soap and water; and avoid sharing personal household items.[57]

In early 2020, the WHO said it was not expected that a vaccine against SARS-CoV-2 could be available in less than 18 months.[58]

Management

There are no specific antiviral medications approved for this disease. Symptoms are managed with supportive care.[59] Both the WHO and Chinese National Health Commission have published detailed treatment recommendations for hospitalized patients with severe acute respiratory infection (SARI) when a SARS-CoV-2 infection is suspected.[60][61] The WHO also recommended volunteers take part in randomized controlled trials for testing the effectiveness and safety of potential treatments.[62]

Bruce Aylward, an assistant director-general of the World Health Organization (WHO), has stated "there is only one drug right now that we think may have real efficacy and that's remdesivir." It was reported on 25 February 2020 that clinical trials for this drug were in progress, with results possibly available within weeks.[63]

The Beijing branch of China's National Health Commission suggested the use of lopinavir/ritonavir as part of treatment plans in the absence of an approved drug for this indication.[64] The lopinavir/ritonavir combination and interferon can now be claimed for via health insurance in some countries.[65]

Chloroquine was being trialed in China in February 2020, with preliminary results that seemed quite positive.[66] The drug was enrolled in treatment guidelines.[66]

Psychological

Infected individuals may experience distress from quarantine, travel restrictions, side effects of treatment, or fear of the infection itself. To address these concerns, the National Health Commission of China published a national guideline for psychological crisis intervention on 27 January 2020.[67][68]

Alternative medicine

Chinese health authorities recommend the use of traditional Chinese medicine (TCM) in addition to standard medical supportive care to prevent or treat the disease. On 22 January, National Health Commission put TCM into the third issue of the COVID diagnostic and treatment plan.[69] On 2 February, Wuhan officials ordered all patients to be put on a specific TCM treatment.[70][71] On 14 February, Wuhan opened a TCM-oriented temporary hospital.[72] The efficacy and safety of TCM has not been established in coronavirus infections.[73][74]

Prognosis

According to WHO, based on analysis of 44,000 cases of COVID-19 in Hubei province, around 80% of people have a mild form of the disease, 14% developed more severe disease such as pneumonia, 5% have critical disease, and 2% of cases are fatal.[75]

Among those who died, many had preexisting conditions, including hypertension, diabetes, or cardiovascular disease,[76] and the median time from initial symptoms to death was 14 days (range 6-41 days).[77] Males had a death rate of 2.8% while females had a death rate of 1.7%.[78] In those under the age of 50 the risk of death is less than 0.5% while in those over the age of 70 it is more than 8%.[78] No deaths have occurred under the age of 10 as of February 26th 2020.[78]

Epidemiology

Overall mortality and morbidity rates due to infection are not well established; while the case fatality rate changes over time in the current outbreak, the proportion of infections that progress to diagnosable disease remains unclear.[79][80] However, preliminary research has yielded case fatality rate numbers between 2% and 3%;[81] in January 2020 the WHO suggested that the case fatality rate was approximately 3%,[82] and 2% in February 2020 in Hubei.[83] An unreviewed preprint study by Imperial College London among 55 fatal cases noted that early estimates of mortality may be too high as asymptomatic infections are missed. They estimated a mean infection fatality ratio (the mortality among infected) ranging from 0.8% when including asymptomatic carriers to 18% when including only symptomatic cases from Hubei province.[84]

Research

Vaccine

Many organizations are using published genomes to develop possible vaccines against SARS-CoV-2.[85][86] Bodies developing vaccines include the Chinese Center for Disease Control and Prevention,[87][88] the University of Hong Kong,[89] and Shanghai East Hospital.[89] Three vaccine projects are being supported by the Coalition for Epidemic Preparedness Innovations (CEPI), including projects by the biotechnology companies Moderna and Inovio Pharmaceuticals and another by the University of Queensland.[90] The United States National Institutes of Health (NIH) is cooperating with Moderna to create an RNA vaccine matching a spike of the coronavirus surface, and intends to start human trials by May 2020.[85] Inovio Pharmaceuticals is developing a DNA-based vaccination and collaborating with a Chinese firm, hoping to perform human trials in the summer of the Northern Hemisphere of 2020.[91] In Australia, the University of Queensland is investigating the potential of a molecular clamp vaccine that would genetically modify viral proteins in order to stimulate an immune reaction.[90] In Canada, the International Vaccine Centre (VIDO-InterVac), University of Saskatchewan, are working on a vaccine,[92] aiming to start animal testing in March 2020 and human testing in 2021.[92]

In January 2020, Janssen Pharmaceutical Companies began work on developing a vaccine, utilizing the same technologies used to make its experimental Ebola vaccine.[93] In the following month, the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) announced that it would collaborate with Janssen and, later, Sanofi Pasteur to develop a vaccine.[94][95] Sanofi has previously worked on a vaccine for SARS and it stated to expect to have a vaccine candidate within six months that could be ready to test in people within a year to 18 months.[94]

On February 26, 2020, a top U.S. health official Dr. Anthony Fauci from the National Institute of Allergy and Infectious Diseases, said that it will take "at least a year to a year and a half at best" to develop a vaccine for the coronavirus, contradicting President Trump, who said one day earlier that "we're very close to a vaccine."[96]

Antiviral

No drug has yet been approved to treat coronavirus infections in humans.[97] Research into potential treatments for the disease was initiated in January 2020, and several antiviral drugs are already in clinical trials.[85][86] Although completely new drugs may take until 2021 to develop,[98] several of the drugs being tested are already approved for other antiviral indications, or are already in advanced testing.[97]

Antivirals being tested include chloroquine,[99] darunavir,[100] galidesivir,[97] interferon beta,[101][better source needed] the lopinavir/ritonavir combination,[99][86] the RNA polymerase inhibitor remdesivir,[102][103][101] and triazavirin.[104][better source needed] Umifenovir (Arbidol) and darunavir were proposed by the National Health Commission.[105][better source needed]

Remdesivir and chloroquine effectively inhibit the coronavirus in vitro.[99]

Preliminary results from a multicentric trial, announced in a press conference and described by Gao, Tian, and Yang, suggested that chloroquine is effective and safe in treating COVID-19 associated pneumonia, "improving lung imaging findings, promoting a virus-negative conversion, and shortening the disease course".[66]

Terminology

The process of naming the disease has been called "chaotic".[106]

The World Health Organization announced on 11 February 2020 that "COVID-19" will be the official name of the disease. World Health Organization chief Tedros Adhanom Ghebreyesus said "co" stands for "corona", "vi" for "virus" and "d" for "disease", while "19" was for the year, as the outbreak was first identified on 31 December 2019. Tedros said the name had been chosen to avoid references to a specific geographical location (i.e. China), animal species, or group of people in line with international recommendations for naming aimed at preventing stigmatization.[107][108]

See also

References

  1. ^ "国家卫生健康委关于新型冠状病毒肺炎暂命名事宜的通知". 7 February 2020. Retrieved 9 February 2020.
  2. ^ "Wuhan pneumonia outbreak: What we know and don't know". 9 January 2020.
  3. ^ "Wuhan pneumonia: Hong Kong widens net but can hospitals cope?". 17 January 2020.
  4. ^ Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. (February 2020). "A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster". Lancet. 395 (10223): 514–523. doi:10.1016/S0140-6736(20)30154-9. PMID 31986261.
  5. ^ "Wuhan designates hospitals for viral pneumonia treatment as cases rise". 21 January 2020.
  6. ^ See SARS-CoV-2 for more.
  7. ^ a b c "Coronavirus Disease 2019 (COVID-19) Symptoms". Centers for Disease Control and Prevention. United States. 10 February 2020.
  8. ^ "What are the official names of the disease and the virus that causes it?". Q&A on coronaviruses. World Health Organization. Retrieved 22 February 2020.
  9. ^ World Health Organization (11 February 2020). Novel Coronavirus (2019-nCoV): situation report, 22 (PDF) (Report). World Health Organization.
  10. ^ a b Gorbalenya AE (11 February 2020). "Severe acute respiratory syndrome-related coronavirus – The species and its viruses, a statement of the Coronavirus Study Group". bioRxiv: 2020.02.07.937862. doi:10.1101/2020.02.07.937862. Archived from the original on 11 February 2020. Retrieved 11 February 2020.
  11. ^ "Coronavirus disease named Covid-19". BBC News. 11 February 2020. Archived from the original on 11 February 2020. Retrieved 11 February 2020.
  12. ^ a b c d Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020 Jan 14;91:264–266. doi:10.1016/j.ijid.2020.01.009. PMID 31953166.open access
  13. ^ a b c "Q&A on coronaviruses". World Health Organization (WHO). Archived from the original on 20 January 2020. Retrieved 27 January 2020.
  14. ^ "Q&A on coronaviruses". World Health Organization (WHO). 11 February 2020. Retrieved 24 February 2020.
  15. ^ "Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention. 11 February 2020. Retrieved 24 February 2020.
  16. ^ "Symptoms of Novel Coronavirus (2019-nCoV) | CDC". www.cdc.gov. 10 February 2020. Archived from the original on 30 January 2020. Retrieved 11 February 2020.
  17. ^ Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR (February 2020). "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges". International Journal of Antimicrobial Agents: 105924. doi:10.1016/j.ijantimicag.2020.105924. PMID 32081636.
  18. ^ "Advice for public". www.who.int. Retrieved 25 February 2020.
  19. ^ "Advice for public". www.who.int. Retrieved 25 February 2020.
  20. ^ a b Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. (February 2020). "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study". Lancet. 395 (10223): 507–513. doi:10.1016/S0140-6736(20)30211-7. PMID 32007143.
  21. ^ a b Hessen MT (27 January 2020). "Novel Coronavirus Information Center: Expert guidance and commentary". Elsevier Connect. Archived from the original on 30 January 2020. Retrieved 31 January 2020.
  22. ^ "Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention (CDC). 15 February 2020. Retrieved 20 February 2020.
  23. ^ "Wuhan Coronavirus Death Rate - Worldometer". www.worldometers.info. Archived from the original on 31 January 2020. Retrieved 2 February 2020.
  24. ^ "Report 4: Severity of 2019-novel coronavirus (nCoV)" (PDF). Archived (PDF) from the original on 10 February 2020. Retrieved 10 February 2020.
  25. ^ CDC (11 February 2020). "2019 Novel Coronavirus (2019-nCoV)". Centers for Disease Control and Prevention. Retrieved 15 February 2020.
  26. ^ "Advice for public". www.who.int. Retrieved 15 February 2020.
  27. ^ "Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)". www.who.int. Archived from the original on 31 January 2020. Retrieved 11 February 2020.
  28. ^ Mahtani S, Berger M, O'Grady S, Iati M (6 February 2020). "Hundreds of evacuees to be held on bases in California; Hong Kong and Taiwan restrict travel from mainland China". The Washington Post.
  29. ^ "Areas with presumed ongoing community transmission of 2019-nCoV". European Centre for Disease Prevention and Control. Archived from the original on 19 February 2020. Retrieved 19 February 2020.
  30. ^ "Areas with presumed ongoing community transmission of 2019-nCoV". European Centre for Disease Prevention and Control. Archived from the original on 28 February 2020. Retrieved 28 February 2020.
  31. ^ Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. (February 2020). "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China". Lancet. 395 (10223): 497–506. doi:10.1016/S0140-6736(20)30183-5. PMID 31986264.
  32. ^ "WHO COVID-19 situation report 29" (PDF). World Health Organization. 19 February 2020.
  33. ^ "Q&A on coronaviruses (COVID-19): How long is the incubation period for COVID-19?". www.who.int. Retrieved 26 February 2020.
  34. ^ "Coronavirus incubation period could be 24 days, say Chinese researchers". 11 February 2020.
  35. ^ "Coronavirus incubation could be as long as 27 days, Chinese provincial government says". Reuters. 22 February 2020.
  36. ^ "2019 Novel Coronavirus (2019-nCoV)". Centers for Disease Control and Prevention. 11 February 2020. Retrieved 18 February 2020.
  37. ^ Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. (23 January 2020). "Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin". bioRxiv: 2020.01.22.914952. doi:10.1101/2020.01.22.914952. Archived from the original on 24 January 2020. Retrieved 5 February 2020.
  38. ^ "The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020" (PDF). China CDC Weekly. 2. 20 February 2020 – via unpublished master.
  39. ^ CDC (5 February 2020). "CDC Tests for 2019-nCoV". Centers for Disease Control and Prevention. Retrieved 12 February 2020.
  40. ^ Schirring L (16 January 2020). "Japan has 1st novel coronavirus case; China reports another death". CIDRAP. Archived from the original on 20 January 2020. Retrieved 16 January 2020.
  41. ^ "Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases: Interim guidance". World Health Organization. Archived from the original on 20 January 2020. Retrieved 28 January 2020.
  42. ^ "2019 Novel Coronavirus (2019-nCoV) Situation Summary". Centers for Disease Control and Prevention. 30 January 2020. Archived from the original on 26 January 2020. Retrieved 30 January 2020.
  43. ^ "Real-Time RT-PCR Panel for Detection 2019-nCoV". Centers for Disease Control and Prevention. 29 January 2020. Archived from the original on 30 January 2020. Retrieved 1 February 2020.
  44. ^ Brueck H (30 January 2020). "There's only one way to know if you have the coronavirus, and it involves machines full of spit and mucus". Business Insider. Archived from the original on 1 February 2020. Retrieved 1 February 2020.
  45. ^ "Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe". GlobeNewswire News Room. 30 January 2020. Archived from the original on 31 January 2020. Retrieved 1 February 2020.
  46. ^ Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases
  47. ^ "Undiagnosed pneumonia – China (HU) (01): wildlife sales, market closed, RFI Archive Number: 20200102.6866757". Pro-MED-mail. International Society for Infectious Diseases. Archived from the original on 22 January 2020. Retrieved 13 January 2020.
  48. ^ Cohen J, Normile D (January 2020). "New SARS-like virus in China triggers alarm" (PDF). Science. 367 (6475): 234–235. doi:10.1126/science.367.6475.234. PMID 31949058. Archived (PDF) from the original on 11 February 2020. Retrieved 11 February 2020.
  49. ^ "Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome". NCBI. Nature. 11 February 2020.
  50. ^ "China Makes Over 1.7 Million Covid-19 Testing Kits per Day, Official Says". Yicai Global.
  51. ^ Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. (February 2020). "A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)". Military Medical Research. 7 (1): 4. doi:10.1186/s40779-020-0233-6. PMC 7003341 Check |pmc= value . PMID 32029004.
  52. ^ "Coronavirus | About | Prevention and Treatment | CDC". www.cdc.gov. 3 February 2020. Archived from the original on 15 December 2019. Retrieved 10 February 2020.
  53. ^ "Advice for public". www.who.int. Archived from the original on 26 January 2020. Retrieved 10 February 2020.
  54. ^ Australian Government Department of Health (21 January 2020). "Coronavirus (COVID-19)". Australian Government Department of Health. Retrieved 15 February 2020.CS1 maint: uses authors parameter (link)
  55. ^ "MOH | Updates on 2019 Novel Coronavirus (2019-nCoV) Local Situation". www.moh.gov.sg. Retrieved 11 February 2020.
  56. ^ Australian Government Department of Health (21 January 2020). "Novel coronavirus (2019-nCoV)". Australian Government Department of Health. Retrieved 11 February 2020.CS1 maint: uses authors parameter (link)
  57. ^ CDC (11 February 2020). "What to do if you are sick with 2019 Novel Coronavirus (2019-nCoV)". Centers for Disease Control and Prevention. Retrieved 13 February 2020.
  58. ^ Grenfell R, Drew T (17 February 2020). "Here's Why It's Taking So Long to Develop a Vaccine For The New Coronavirus". Science Alert.
  59. ^ Kui L, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. (February 2020). "Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province". Chinese Medical Journal: 1. doi:10.1097/CM9.0000000000000744. PMID 32044814.
  60. ^ Cheng ZJ, Shan J (February 2020). "2019 Novel coronavirus: where we are and what we know" (PDF). Infection. doi:10.1007/s15010-020-01401-y. PMID 32072569.
  61. ^ "Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected". www.who.int. Retrieved 13 February 2020.
  62. ^ Nebehay S, Kelland K, Liu R (5 February 2020). "WHO: 'no known effective' treatments for new coronavirus". Thomson Reuters. Archived from the original on 5 February 2020. Retrieved 5 February 2020.
  63. ^ La Monica PR (25 February 2020). "Gilead Sciences drug remdesivir may help treat coronavirus symptoms, according to WHO". CNN.
  64. ^ "China names HIV drugs as part of treatment plan for Wuhan virus". The Japan Times Online. 26 January 2020. ISSN 0447-5763. Retrieved 14 February 2020.
  65. ^ "Interferon, Kaletra to get insurance benefit for new coronavirus treatment - Korea Biomedical Review". www.koreabiomed.com (in Korean). 4 February 2020. Retrieved 14 February 2020.
  66. ^ a b c Gao J, Tian Z, Yang X (February 2020). "Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies". Bioscience Trends. doi:10.5582/bst.2020.01047. PMID 32074550.
  67. ^ Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, Ng CH (March 2020). "Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed". The Lancet. Psychiatry. 7 (3): 228–229. doi:10.1016/S2215-0366(20)30046-8. PMID 32032543.
  68. ^ Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX, et al. (March 2020). "The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus". The Lancet. Psychiatry. 7 (3): e14. doi:10.1016/S2215-0366(20)30047-X. PMID 32035030.
  69. ^ "新冠肺炎治疗:讲究实证的西医和自我定位的中药" [Treating the novel conoravirus: the empirical Western medicine and the self-positioning Chinese medicine]. BBC News (in Chinese). 14 February 2020.
  70. ^ "中医来了!8个防治"协定方" 辅助治疗新型冠状病毒感染肺炎" [Here comes Chinese medicine! 8 "agreed-on prescriptions" help prevent and treat the new coronavirus pneumonia]. CCTV News. Retrieved 15 February 2020.
  71. ^ "武汉要求所有患者必须吃中药 网民质疑" [Wuhan wants all patients put on TCM; Netizens question]. Epoch Times (in Chinese). 4 February 2020. Retrieved 15 February 2020.
  72. ^ "Virus-hit Wuhan opens first TCM-oriented temporary hospital". Xinhua.
  73. ^ "Dispelling the myths around the new coronavirus outbreak". www.aljazeera.com. Retrieved 8 February 2020.
  74. ^ Wee S (5 February 2020). "In Coronavirus, China Weighs Benefits of Buffalo Horn and Other Remedies". The New York Times.
  75. ^ The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. "The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020". China CDC Weekly 2020.
  76. ^ "WHO Director-General's statement on the advice of the IHR Emergency Committee on Novel Coronavirus". who.int.
  77. ^ Wang W, Tang J, Wei F (April 2020). "Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China". Journal of Medical Virology. 92 (4): 441–447. doi:10.1002/jmv.25689. PMID 31994742.
  78. ^ a b c "Coronavirus Age, Sex, Demographics (COVID-19) - Worldometer". www.worldometers.info. Retrieved 26 February 2020.
  79. ^ "Limited data on coronavirus may be skewing assumptions about severity". STAT. 30 January 2020. Archived from the original on 1 February 2020. Retrieved 1 February 2020.
  80. ^ Sparrow A. "How China's Coronavirus Is Spreading—and How to Stop It". Foreign Policy. Archived from the original on 31 January 2020. Retrieved 2 February 2020.
  81. ^ "Wuhan Coronavirus Death Rate - Worldometer". www.worldometers.info. Archived from the original on 31 January 2020. Retrieved 2 February 2020.
  82. ^ "WHOが"致死率3%程度" 専門家「今後 注意が必要」". NHK. 24 January 2020. Archived from the original on 26 January 2020. Retrieved 3 February 2020.
  83. ^ Boseley, Sarah (17 February 2020). "Coronavirus causes mild disease in four in five patients, says WHO". The Guardian.
  84. ^ "Report 4: Severity of 2019-novel coronavirus (nCoV)" (PDF). Archived (PDF) from the original on 10 February 2020. Retrieved 10 February 2020.
  85. ^ a b c Steenhuysen J, Kelland K (24 January 2020). "With Wuhan virus genetic code in hand, scientists begin work on a vaccine". Reuters. Archived from the original on 25 January 2020. Retrieved 25 January 2020.
  86. ^ a b c Praveen Duddu. Coronavirus outbreak: Vaccines/drugs in the pipeline for Covid-19. clinicaltrialsarena.com 19 February 2020.
  87. ^ "China CDC developing novel coronavirus vaccine". Xinhua. 26 January 2020. Archived from the original on 26 January 2020. Retrieved 28 January 2020.
  88. ^ "Chinese scientists race to develop vaccine as coronavirus death toll jumps". South China Morning Post. 26 January 2020. Archived from the original on 26 January 2020. Retrieved 28 January 2020.
  89. ^ a b Cheung E (28 January 2020). "Hong Kong researchers have developed coronavirus vaccine, expert reveals". South China Morning Post. Archived from the original on 28 January 2020. Retrieved 28 January 2020.
  90. ^ a b Devlin H (24 January 2020). "Lessons from SARS outbreak help in race for coronavirus vaccine". The Guardian. Archived from the original on 25 January 2020. Retrieved 25 January 2020.
  91. ^ Mazumdar T (30 January 2020). "Coronavirus: Scientists race to develop a vaccine". BBC News Online. Archived from the original on 30 January 2020. Retrieved 3 February 2020.
  92. ^ a b "Saskatchewan lab joins global effort to develop coronavirus vaccine". Canadian Broadcasting Corporation. 24 January 2020. Archived from the original on 25 January 2020. Retrieved 25 January 2020.
  93. ^ Mishra M (29 January 2020). "Johnson & Johnson working on vaccine for deadly coronavirus". Reuters. Archived from the original on 29 January 2020. Retrieved 19 February 2020.
  94. ^ a b Branswell H (18 February 2020). "Sanofi announces it will work with HHS to develop coronavirus vaccine". STAT. Retrieved 19 February 2020.
  95. ^ "HHS Engages Sanofi's Recombinant Technology for 2019 Novel Coronavirus Vaccine". U.S. Department of Health & Human Services (HHS) (Press release). 14 February 2020. Retrieved 19 February 2020.
  96. ^ Deese K (26 February 2020). "Health official says coronavirus vaccine will take 'at least a year to a year and a half' to develop". TheHill. Retrieved 26 February 2020.
  97. ^ a b c Li G, De Clercq E (2020). "Therapeutic options for the 2019 novel coronavirus (2019-nCoV)". Nature Reviews Drug Discovery. doi:10.1038/d41573-020-00016-0.
  98. ^ Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 28 Jan 2020. doi:10.5582/bst.2020.01020
  99. ^ a b c Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. (February 2020). "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro". Cell Research. doi:10.1038/s41422-020-0282-0. PMID 32020029.
  100. ^ Lin S, Shen R, He J, Li X, Guo X (January 2020). "Molecular Modeling Evaluation of the Binding Effect of Ritonavir, Lopinavir and Darunavir to Severe Acute Respiratory Syndrome Coronavirus 2 Proteases" (PDF). bioRxiv. doi:10.1101/2020.01.31.929695.
  101. ^ a b Paules CI, Marston HD, Fauci AS (January 2020). "Coronavirus Infections-More Than Just the Common Cold". JAMA. 323 (8): 707. doi:10.1001/jama.2020.0757. PMID 31971553.
  102. ^ Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. (January 2020). "First Case of 2019 Novel Coronavirus in the United States". The New England Journal of Medicine: NEJMoa2001191. doi:10.1056/NEJMoa2001191. PMID 32004427.
  103. ^ Xu Z, Peng C, Shi Y, Zhu Z, Mu K, Wang X, Zhu W (28 January 2020). "Nelfinavir was predicted to be a potential inhibitor of 2019 nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation". bioRxiv: 2020.01.27.921627. doi:10.1101/2020.01.27.921627 – via www.biorxiv.org.
  104. ^ "China to test Russian antiviral for battle against coronavirus". Washington post. Retrieved 20 February 2020.
  105. ^ "Are cocktail therapies for flu and HIV the magic cure for coronavirus?". South China Morning Post. 4 February 2020. Retrieved 22 February 2020.
  106. ^ Enserink M (12 February 2020). "Update: 'A bit chaotic.' Christening of new coronavirus and its disease name create confusion". American Associaton for the Advancement of Science. Science Magazine. Retrieved 27 February 2020.
  107. ^ "Novel coronavirus named 'Covid-19': WHO". TODAYonline. Retrieved 11 February 2020.
  108. ^ "The coronavirus spreads racism against—and among—ethnic Chinese". The Economist. 17 February 2020.

本页面最后更新于2020-02-28 11:43,点击更新本页查看原网页

本站的所有资料包括但不限于文字、图片等全部转载于维基百科(wikipedia.org),遵循 维基百科:CC BY-SA 3.0协议

万维百科为维基百科爱好者建立的公益网站,旨在为中国大陆网民提供优质内容,因此对部分内容进行改编以符合中国大陆政策,如果您不接受,可以直接访问维基百科官方网站


顶部

如果本页面有数学、化学、物理等公式未正确显示,请使用火狐或者Safari浏览器